… a cushingoid appearance, proximal myopathy and hyperglycaemia. Mycophenolate mofetil was initiated as a steroid-sparing agent with significant impro…
mycophenolate mofetil
This drug is selected. Its supporting articles are shown below.
Articles mentioning mycophenolate mofetil
100 articles · page 8 of 9… of 22.2 months (95% CI 18.1–26.2), 51% of patients interrupted nintedanib due to diarrhoea (33%), nausea/vomiting (21%), reflux (2%), wei…
… high-dose corticosteroids, six sessions of plasmapheresis, and rituximab. Due to persistent pancytopenia with febrile neutropenia, empir…
…M, Sutton E, Nesbit S, et al. Short-term efficacy and safety of rituximab therapy in refractory systemic lupus erythematosus: results fro…
…enty-eight percent of patients were not exposed to thiopurines. Mycophenolate mofetil (MMF) was initiated in 68 patients (73.1%). MMF treatment was d…
…patient with IBD-U/PSC. IBD/AIH/AISC subtypes were treated with prednisolone (61.5%), azathioprine (76.9%) or mycophenolate mofetil (15.4%).…
…ere achieved by 37/59 (62.7%) and 33/59 (55.9%) patients in the avacopan group and 34/57 (59.6%) and 30/57 (52.6%) in the prednisone tap…
…ience supporting its long-term use. Among biological therapies, infliximab and rituximab have taken a leading role in the management of re…
… on Cancer stage IV (8th edition).Results All patients received ipilimumab plus nivolumab. The Eastern Cooperative Oncology Group performa…
…ne, transitioned to tapering oral prednisolone and initiated on mycophenolate mofetil. Her diplopia resolved completely and muscle enzyme levels norm…
…enance therapy. This study evaluates the efficacy and safety of mycophenolate mofetil (MMF) as long-term adjunctive therapy to first-line treatment i…
…s.She was treated with oral steroids, mycophenolate mofetil and adalimumab. At 6 months she underwent transfemoral coronary, pulmonary, pe…